Asia-Pacific anticoagulants market is estimated to grow at a CAGR of 7.8% during the forecast period. The rising prevalence of CVD is supporting to drive the adoption of anticoagulants in the region. CVD burden has been rising dramatically in the region owing to the rising aging population and rising prevalence of risk factors, including diabetes, hypertension, and smoking. The rising obese population is also a major risk factor for the rising CVD incidences in the region. The Chinese population is becoming increasingly overweight or obese, which has increased the risk of CVD in the country. This, in turn, is resulting in an increasing demand for anticoagulants that are used to prevent the blood from clotting as rapidly or as potentially as normal. Anticoagulants are also known as blood thinners. These medications are used for the treatment and prevention of blood clots that may occur in the blood vessels.
Get Free Sample link @ https://www.omrglobal.com/request-sample/asia-pacific-anticoagulants-market
The market is segmented based on type and application. Based on type, the market is classified into novel oral anticoagulants (NOACs), vitamin k antagonist, and heparin, and low molecular weight heparin (LMWH). Increasing demand for NOACs has been reported in the region as it has demonstrated tremendous safety and efficacy without the requirement of subsequent dose adjustment and frequent monitoring. Based on application, the market is classified into a pulmonary embolism, atrial fibrillation/myocardial infarction (heart attack), deep vein thrombosis, and others.
A full report of Asia-Pacific Anticoagulants Market available @ https://www.omrglobal.com/industry-reports/asia-pacific-anticoagulants-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Asia-Pacific Anticoagulants Market by Type
- Novel Oral Anticoagulants (NOACs)
- Vitamin K Antagonist
- Heparin and Low Molecular Weight Heparin (LMWH)
Asia-Pacific Anticoagulants Market by Application
- Pulmonary Embolism
- Atrial Fibrillation/Myocardial Infarction (Heart Attack)
- Deep Vein Thrombosis (DVT)
- Others
Regional Analysis
- China
- India
- Japan
- Rest of Asia-Pacific
Company Profiles
- AstraZeneca plc
- Overview
- Product Portfolio
- Recent Activities
- Bristol Myers Squibb Co.
- Cipla Ltd.
- Daiichi Sankyo Company, Ltd.
- Reddy’s Laboratories
- Johnson & Johnson Services, Inc.
- Lupin Ltd.
- Novartis International AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
The Report Covers
- Comprehensive research methodology of the Asia-Pacific anticoagulants market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Asia-Pacific anticoagulants market.
- Insights about market determinants that are stimulating the Asia-Pacific anticoagulants market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-anticoagulants-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
